COMMUNIQUÉS West-GlobeNewswire

-
MDBriefCase Group annonce de nouveaux conseillers experts et transforme sa plateforme de formation numérique
18/09/2019 -
ALR Technologies to Integrate with CGM Platforms
18/09/2019 -
Artelo Biosciences Cannabidiol (CBD) Studies Referenced in September Issue of Nature Medicine
18/09/2019 -
HealthLynked Corp. Announces the Addition of Shawn Miller M.D. to its Medical Advisory Board
18/09/2019 -
New Data Presented on Blood Volume at Annual Heart Failure Society Meeting Amid Call to Broadly Adopt Daxor’s Diagnostic Technology
18/09/2019 -
aTyr Pharma to Participate in September Conferences
18/09/2019 -
First Patient Enrolled in Landmark CareDx OKRA Registry
18/09/2019 -
Biogen Advances Spinal Muscular Atrophy (SMA) Clinical Research with New Study Evaluating a Higher Dose of SPINRAZA® (nusinersen) and Additional Data in a Broad Range of Patients
18/09/2019 -
Paralympic Skier Danelle Umstead Teams Up with Spark Therapeutics to Help People Living with Inherited Retinal Diseases (IRDs) Access Genetic Testing
18/09/2019 -
Auxly and Kindred Announce Canadian Brokerage Agreement
18/09/2019 -
AgraFlora Organics Awarded Cannabis Research License from Health Canada
18/09/2019 -
AgraFlora Organics obtient une licence de recherche sur le cannabis de la part de Santé Canada
18/09/2019 -
MiniMed™ 670G System European Real-World Data Shows 73% Time in Range, Beyond Recommended Targets
18/09/2019 -
MiniMed™ 670G System European Real-World Data Shows 73% Time in Range, Beyond Recommended Targets
18/09/2019 -
Chi-Med Highlights Oral Presentations at 2019 CSCO Annual Meeting
18/09/2019 -
Summit Announces Publication of Editorial in Future Microbiology Advocating for Innovation in Antibiotic Development to Drive Stewardship Focus on Improving Patient Outcomes
18/09/2019 -
Saniona reports positive Tesomet Phase 2a clinical results in adolescent patients with Prader-Willi syndrome
18/09/2019 -
Curetis Reports Financial Results for the First Six Months of 2019
18/09/2019 -
FDA grants Breakthrough Therapy Designation for Roche’s Gazyva (obinutuzumab) in Lupus Nephritis
18/09/2019
Pages